{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:42:43Z","timestamp":1762101763955},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/cgt.2015.38","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T10:26:10Z","timestamp":1442571970000},"page":"431-437","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity"],"prefix":"10.1038","volume":"22","author":[{"given":"F-F","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X-J","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-D","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X-J","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"BFcgt201538_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E . Cancer statistics. CA Cancer J Clin 2010; 60: 277\u2013300.","journal-title":"CA Cancer J Clin"},{"key":"BFcgt201538_CR2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1349-7006.2005.00113.x","volume":"96","author":"T Tsuchiya","year":"2005","unstructured":"Tsuchiya T, Okaji Y, Tsuno NH, Sakurai D, Tsuchiya N, Kawai K et al. Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci 2005; 96: 784\u2013790.","journal-title":"Cancer Sci"},{"key":"BFcgt201538_CR3","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1073\/pnas.0801505105","volume":"105","author":"A Swarbrick","year":"2008","unstructured":"Swarbrick A, Roy E, Allen T, Bishop JM . Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci USA 2008; 105: 5402\u20135407.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201538_CR4","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1038\/sj.onc.1206693","volume":"22","author":"MT Ling","year":"2003","unstructured":"Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC . Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene 2003; 22: 4498\u20134508.","journal-title":"Oncogene"},{"key":"BFcgt201538_CR5","doi-asserted-by":"publisher","first-page":"19506","DOI":"10.1073\/pnas.0709185104","volume":"104","author":"GP Gupta","year":"2007","unstructured":"Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA 2007; 104: 19506\u201319511.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201538_CR6","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1158\/1078-0432.CCR-07-4716","volume":"14","author":"L Kamalian","year":"2008","unstructured":"Kamalian L, Gosney JR, Forootan SS, Foster CS, Bao ZZ, Beesley C et al. Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res 2008; 14: 2318\u20132325.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201538_CR7","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1210\/jc.2004-1234","volume":"89","author":"E Kebebew","year":"2004","unstructured":"Kebebew E, Peng M, Treseler PA, Clark OH, Duh QY, Ginzinger D et al. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells. J Clin Endocrinol Metab 2004; 89: 6105\u20136111.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcgt201538_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/1471-2407-9-430","volume":"9","author":"MK Maw","year":"2009","unstructured":"Maw MK, Fujimoto J, Tamaya T . Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer 2009; 9: 430.","journal-title":"BMC Cancer"},{"key":"BFcgt201538_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ejca.2005.11.016","volume":"42","author":"Y Okaji","year":"2006","unstructured":"Okaji Y, Tsuno NH, Kitayama J, Sakurai D, Tsuchiya N, Saito S et al. Effects of down-regulating the Id genes in human colorectal cancer cells on early steps of haematogenous metastasis. Eur J Cancer 2006; 42: 668\u2013673.","journal-title":"Eur J Cancer"},{"key":"BFcgt201538_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2121-11-2","volume":"11","author":"C Manthey","year":"2010","unstructured":"Manthey C, Mern DS, Gutmann A, Zielinski AJ, Herz C, Lassmann S et al. Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells. BMC Cell Biol 2010; 11: 2.","journal-title":"BMC Cell Biol"},{"key":"BFcgt201538_CR11","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1073\/pnas.88.5.1815","volume":"88","author":"BA Christy","year":"1991","unstructured":"Christy BA, Sanders LK, Lau LF, Copeland NG, Jenkins NA, Nathans D . An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc Natl Acad Sci USA 1991; 88: 1815\u20131819.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201538_CR12","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/j.1745-7254.2005.00207.x","volume":"26","author":"RW Lim","year":"2005","unstructured":"Lim RW, Wu JM . Molecular mechanisms regulating expression and function of transcription regulator inhibitor of differentiation 3. Acta Pharmacol Sin 2005; 26: 1409\u20131420.","journal-title":"Acta Pharmacol Sin"},{"key":"BFcgt201538_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/85303","volume":"2","author":"BL Kee","year":"2001","unstructured":"Kee BL, Rivera RR, Murre C . Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat Immunol 2001; 2: 242\u2013247.","journal-title":"Nat Immunol"},{"key":"BFcgt201538_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1073\/pnas.0802550106","volume":"106","author":"MA Thal","year":"2009","unstructured":"Thal MA, Carvalho TL, He T, Kim HG, Gao H, Hagman J et al. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc Natl Acad Sci USA 2009; 106: 552\u2013557.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201538_CR15","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.4049\/jimmunol.0903218","volume":"184","author":"ES Alonzo","year":"2010","unstructured":"Alonzo ES, Gottschalk RA, Das J, Egawa T, Hobbs RM, Pandolfi PP et al. Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3. J Immunol 2010; 184: 1268\u20131279.","journal-title":"J Immunol"},{"key":"BFcgt201538_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ni.1965","volume":"12","author":"T Maruyama","year":"2011","unstructured":"Maruyama T, Li J, Vaque JP, Konkel JE, Wang W, Zhang B et al. Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat Immunol 2011; 12: 86\u201395.","journal-title":"Nat Immunol"},{"key":"BFcgt201538_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2007.12.048","volume":"198","author":"Q Felty","year":"2008","unstructured":"Felty Q, Porther N . Estrogen-induced redox sensitive Id3 signaling controls the growth of vascular cells. Atherosclerosis 2008; 198: 12\u201321.","journal-title":"Atherosclerosis"},{"key":"BFcgt201538_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11010-009-0201-7","volume":"333","author":"K Wassmann","year":"2010","unstructured":"Wassmann K, Mueller CF, Becher UM, Werner C, Jung A, Zimmer S et al. Interaction of Inhibitor of DNA binding 3 (Id3) with Gut-enriched Kruppel-like factor (GKLF) and p53 regulates proliferation of vascular smooth muscle cells. Mol Cell Biochem 2010; 333: 33\u201339.","journal-title":"Mol Cell Biochem"},{"key":"BFcgt201538_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ydbio.2010.10.004","volume":"349","author":"Q Zhao","year":"2011","unstructured":"Zhao Q, Beck AJ, Vitale JM, Schneider JS, Gao S, Chang C et al. Developmental ablation of Id1 and Id3 genes in the vasculature leads to postnatal cardiac phenotypes. Dev Biol 2011; 349: 53\u201364.","journal-title":"Dev Biol"},{"key":"BFcgt201538_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jss.2008.10.031","volume":"161","author":"Y Shuno","year":"2010","unstructured":"Shuno Y, Tsuno NH, Okaji Y, Tsuchiya T, Sakurai D, Nishikawa T et al. Id1\/Id3 knockdown inhibits metastatic potential of pancreatic cancer. J Surg Res 2010; 161: 76\u201382.","journal-title":"J Surg Res"},{"key":"BFcgt201538_CR21","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1158\/1078-0432.CCR-07-4716","volume":"14","author":"L Kamalian","year":"2008","unstructured":"Kamalian L, Gosney JR, Forootan SS et al. Increased expression of ID family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res 2008; 14: 2318\u20132325.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201538_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molmed.2004.06.008","volume":"10","author":"S Fong","year":"2004","unstructured":"Fong S, Debs RJ, Desprez PY . Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 2004; 10: 387\u2013392.","journal-title":"Trends Mol Med"},{"key":"BFcgt201538_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1054\/bjoc.2000.1620","volume":"84","author":"JM Arnold","year":"2001","unstructured":"Arnold JM, Mok SC, Purdie D, Chenevix-Trench G . Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas. Br J Cancer 2001; 84: 352\u2013359.","journal-title":"Br J Cancer"},{"key":"BFcgt201538_CR24","first-page":"319","volume":"26","author":"B Damdinsuren","year":"2005","unstructured":"Damdinsuren B, Nagano H, Kondo M, Yamamoto H, Hiraoka N, Yamamoto T et al. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Int J Oncol 2005; 26: 319\u2013327.","journal-title":"Int J Oncol"},{"key":"BFcgt201538_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/bab.17","volume":"58","author":"XJ Li","year":"2011","unstructured":"Li XJ, Jia L, Chen FF, Zhong AF, Yu W, Wang K et al. Soluble expression of human Id(3) in Escherichia coli and generation and application of its polyclonal antibodies. Biotechnol Appl Biochem 2011; 58: 91\u201396.","journal-title":"Biotechnol Appl Biochem"},{"key":"BFcgt201538_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2184.2011.00792.x","volume":"45","author":"XJ Li","year":"2012","unstructured":"Li XJ, Zhu CD, Yu W, Wang P, Chen FF, Xia XY et al. Overexpression of Id3 induces apoptosis of A549 human lung adenocarcinoma cells. Cell Prolif 2012; 45: 1\u20138.","journal-title":"Cell Prolif"},{"key":"BFcgt201538_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1158\/1541-7786.MCR-10-0535","volume":"9","author":"SH Lee","year":"2011","unstructured":"Lee SH, Hao E, Kiselyuk A, Shapiro J, Shields DJ, Lowy A et al. The Id3\/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma. Mol Cancer Res 2011; 9: 782\u2013790.","journal-title":"Mol Cancer Res"},{"key":"BFcgt201538_CR28","first-page":"595","volume":"37","author":"L Kamalian","year":"2010","unstructured":"Kamalian L, Forootan SS, Bao ZZ, Zhang Y, Gosney JR, Foster CS et al. Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression. Int J Oncol 2010; 37: 595\u2013603.","journal-title":"Int J Oncol"},{"key":"BFcgt201538_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10549-010-0810-6","volume":"124","author":"DS Mern","year":"2010","unstructured":"Mern DS, Hoppe-Seyler K, Hoppe-Seyler F, Hasskarl J, Burwinkel B . Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells. Breast Cancer Res Treat 2010; 124: 623\u2013633.","journal-title":"Breast Cancer Res Treat"},{"key":"BFcgt201538_CR30","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.4049\/jimmunol.173.4.2453","volume":"173","author":"K Hata","year":"2004","unstructured":"Hata K, Yoshimoto T, Mizuguchi J . CD40 ligand rescues inhibitor of differentiation 3-mediated G1 arrest induced by anti-IgM in WEHI-231 B lymphoma cells. J Immunol 2004; 173: 2453\u20132461.","journal-title":"J Immunol"},{"key":"BFcgt201538_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1745-7254.2005.00067.x","volume":"26","author":"XJ Li","year":"2005","unstructured":"Li XJ, Hata K, Mizuguchi J . Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells. Acta Pharmacol Sin 2005; 26: 486\u2013491.","journal-title":"Acta Pharmacol Sin"},{"key":"BFcgt201538_CR32","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1038\/sj.onc.1209407","volume":"25","author":"CM Simbulan-Rosenthal","year":"2006","unstructured":"Simbulan-Rosenthal CM, Daher A, Trabosh V, Chen WC, Gerstel D, Soeda E et al. Id3 induces a caspase-3- and -9-dependent apoptosis and mediates UVB sensitization of HPV16 E6\/7 immortalized human keratinocytes. Oncogene 2006; 25: 3649\u20133660.","journal-title":"Oncogene"},{"key":"BFcgt201538_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1600-0625.2008.00801.x","volume":"18","author":"VA Trabosh","year":"2009","unstructured":"Trabosh VA, Daher A, Divito KA, Amin K, Simbulan-Rosenthal CM, Rosenthal DS . UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3. Exp Dermatol 2009; 18: 387\u2013395.","journal-title":"Exp Dermatol"},{"key":"BFcgt201538_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jdermsci.2010.09.002","volume":"60","author":"YS Lee","year":"2010","unstructured":"Lee YS, Mollah ML, Sohn KC, Shi G, Kim DH, Kim KH et al. ID3 mediates X-ray-induced apoptosis of keratinocytes through the regulation of beta-catenin. J Dermatol Sci 2010; 60: 138\u2013142.","journal-title":"J Dermatol Sci"},{"key":"BFcgt201538_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1476-4598-12-129","volume":"12","author":"E Langenfeld","year":"2013","unstructured":"Langenfeld E, Deen M, Zachariah E, Langenfeld J . Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin. Mol Cancer 2013; 12: 129.","journal-title":"Mol Cancer"},{"key":"BFcgt201538_CR36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.18632\/genesandcancer.20","volume":"5","author":"D Chen","year":"2014","unstructured":"Chen D, Forootan SS, Gosney JR, Forootan FS, Ke Y . Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer. Genes Cancer 2014; 5: 212\u2013225.","journal-title":"Genes Cancer"},{"key":"BFcgt201538_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1479-5876-11-13","volume":"11","author":"E Casta\u00f1on","year":"2013","unstructured":"Casta\u00f1on E, Bosch-Barrera J, L\u00f3pez I, Collado V, Moreno M, L\u00f3pez-Picazo JM . Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy. J Transl Med 2013; 11: 13.","journal-title":"J Transl Med"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201538","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:30:05Z","timestamp":1647952205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFcgt201538"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2015.38","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"25 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}